Primary immunization of Rh-negative volunteers

Area of Science:

• Immunology
• Transfusion Medicine

Background:

• Anti-D immunoglobulin is vital for preventing hemolytic disease of the newborn in Rh-negative women.
• Standardized and effective methods for producing anti-D serum are essential for clinical applications.

Purpose of the Study:

• To establish the optimal dosage of R(2)R(2) red blood cells for primary immunization to produce high-titre anti-D serum.
• To evaluate the efficacy of different immunization doses in Rh-negative male volunteers.

Main Methods:

• Two groups of Rh-negative male volunteers received intravenous injections of washed group O R(2)R(2) cells.
• Group 1 received 5 ml of packed cells; Group 2 received 0.5 ml of packed cells.
• Serum samples were analyzed for the development of anti-D antibodies over several weeks.

Main Results:

• Both 5 ml and 0.5 ml doses of R(2)R(2) cells were highly effective, with only one failure in each group.
• The 0.5 ml dose was concluded to be a satisfactory volume for producing anti-D.
• Initial antibodies detected were primarily 7S gammaG immunoglobulins, with a minor 19S gammaM component in some cases.

Conclusions:

• A dose of 0.5 ml of packed R(2)R(2) cells is sufficient for primary immunization to produce high-titre anti-D serum.
• The study confirms the feasibility of generating anti-D immunoglobulin with a reduced cell volume.
• The antibody response involves the initial appearance of 7S gammaG and 19S gammaM immunoglobulins.